Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (2)
P 4 (4)

Trial Status

Unknown3
Withdrawn2
Active Not Recruiting1
Recruiting1

Clinical Trials (7)

Showing 7 of 7 trials
NCT02845531Phase 4RecruitingPrimary

Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

NCT03477890Not ApplicableActive Not Recruiting

Coronary Microvascular Function and CT Coronary Angiography (CorCTCA)

NCT02932553Phase 4WithdrawnPrimary

BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease

NCT05618132Not ApplicableUnknownPrimary

ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs

NCT02790528Phase 4WithdrawnPrimary

Statin Therapy In Patients With Vasospastic Angina

NCT01318629Unknown

Angina in Non Coronary Artery Disease

NCT00620204Phase 4UnknownPrimary

Efficacy Study of Atorvastatin to Treat Variant Angina

Showing all 7 trials

Research Network

Activity Timeline